BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benedict RH, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R;  Multiple Sclerosis Outcome Assessments Consortium. Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis. Mult Scler. 2017;23:721-733. [PMID: 28206827 DOI: 10.1177/1352458517690821] [Cited by in Crossref: 309] [Cited by in F6Publishing: 227] [Article Influence: 77.3] [Reference Citation Analysis]
Number Citing Articles
1 Bernabéu-Sanz Á, Morales S, Naranjo V, Sempere ÁP. Contribution of Gray Matter Atrophy and White Matter Damage to Cognitive Impairment in Mildly Disabled Relapsing-Remitting Multiple Sclerosis Patients. Diagnostics (Basel) 2021;11:578. [PMID: 33807060 DOI: 10.3390/diagnostics11030578] [Reference Citation Analysis]
2 Mooijaart SP, Du Puy RS, Stott DJ, Kearney PM, Rodondi N, Westendorp RGJ, den Elzen WPJ, Postmus I, Poortvliet RKE, van Heemst D, van Munster BC, Peeters RP, Ford I, Kean S, Messow CM, Blum MR, Collet TH, Watt T, Dekkers OM, Jukema JW, Smit JWA, Langhorne P, Gussekloo J. Association Between Levothyroxine Treatment and Thyroid-Related Symptoms Among Adults Aged 80 Years and Older With Subclinical Hypothyroidism. JAMA 2019;322:1977-86. [PMID: 31664429 DOI: 10.1001/jama.2019.17274] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 13.5] [Reference Citation Analysis]
3 Araujo N, Morais S, Costa AR, Braga R, Carneiro AF, Cruz VT, Ruano L, Oliveira J, Figueiredo LP, Pereira S, Lunet N. Cognitive decline in patients with prostate cancer: study protocol of a prospective cohort, NEON-PC. BMJ Open 2021;11:e043844. [PMID: 33589462 DOI: 10.1136/bmjopen-2020-043844] [Reference Citation Analysis]
4 Xu XM, Jiao Y, Tang TY, Lu CQ, Zhang J, Salvi R, Teng GJ. Altered Spatial and Temporal Brain Connectivity in the Salience Network of Sensorineural Hearing Loss and Tinnitus. Front Neurosci 2019;13:246. [PMID: 30941010 DOI: 10.3389/fnins.2019.00246] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
5 Meli R, Roccatagliata L, Capello E, Bruschi N, Uccelli A, Mancardi G, Inglese M, Pardini M. Ecological impact of isolated cognitive relapses in MS. Mult Scler 2020;26:114-7. [DOI: 10.1177/1352458518813722] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
6 van Oirschot P, Heerings M, Wendrich K, den Teuling B, Martens MB, Jongen PJ. Symbol Digit Modalities Test Variant in a Smartphone App for Persons With Multiple Sclerosis: Validation Study. JMIR Mhealth Uhealth 2020;8:e18160. [PMID: 33016886 DOI: 10.2196/18160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 van Dongen L, Westerik B, van der Hiele K, Visser LH, Schoonheim MM, Douw L, Twisk JWR, de Jong BA, Geurts JJG, Hulst HE. Introducing Multiple Screener: An unsupervised digital screening tool for cognitive deficits in MS. Mult Scler Relat Disord 2020;38:101479. [PMID: 31760365 DOI: 10.1016/j.msard.2019.101479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Satchidanand N, Drake A, Smerbeck A, Hojnacki D, Kolb C, Patrick K, Weinstock-guttman B, Motl R, Benedict RH. Dalfampridine benefits ambulation but not cognition in multiple sclerosis. Mult Scler 2020;26:91-8. [DOI: 10.1177/1352458518815795] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
9 Hsu WY, Rowles W, Anguera JA, Zhao C, Anderson A, Alexander A, Sacco S, Henry R, Gazzaley A, Bove R. Application of an Adaptive, Digital, Game-Based Approach for Cognitive Assessment in Multiple Sclerosis: Observational Study. J Med Internet Res 2021;23:e24356. [PMID: 33470940 DOI: 10.2196/24356] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Corfield F, Langdon D. A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS). Neurol Ther 2018;7:287-306. [PMID: 29923070 DOI: 10.1007/s40120-018-0102-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
11 Saymuah S, Laird H, Nitta M, Atalla M, Fritz NE. Motor, Cognitive, and Behavioral Performance in Middle-Aged and Older Adults With Multiple Sclerosis. Topics in Geriatric Rehabilitation 2019;35:199-208. [DOI: 10.1097/tgr.0000000000000235] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Klein OA, das Nair R, Ablewhite J, Drummond A. Assessment and management of cognitive problems in people with multiple sclerosis: A National Survey of Clinical Practice. Int J Clin Pract 2018;:e13300. [PMID: 30507025 DOI: 10.1111/ijcp.13300] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
13 Rao SM. Role of Computerized Screening in Healthcare Teams: Why Computerized Testing is Not the Death of Neuropsychology. Archives of Clinical Neuropsychology 2018;33:375-8. [DOI: 10.1093/arclin/acx137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
14 Wojcik C, Fuchs TA, Tran H, Dwyer MG, Jakimovski D, Unverdi M, Weinstock-Guttman B, Zivadinov R, Eshaghi A, Benedict RH. Staging and stratifying cognitive dysfunction in multiple sclerosis. Mult Scler 2021;:13524585211011390. [PMID: 33951975 DOI: 10.1177/13524585211011390] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gedizlioglu M, Koskderelioglu A, Vural M, Tiftikcioglu IB. Cognition in acute relapses: A psychometric evaluation and its correlation with event-related potential, P300 in multiple sclerosis. Appl Neuropsychol Adult 2021;:1-10. [PMID: 33749422 DOI: 10.1080/23279095.2021.1897815] [Reference Citation Analysis]
16 Buyukturkoglu K, Zeng D, Bharadwaj S, Tozlu C, Mormina E, Igwe KC, Lee S, Habeck C, Brickman AM, Riley CS, De Jager PL, Sumowski JF, Leavitt VM. Classifying multiple sclerosis patients on the basis of SDMT performance using machine learning. Mult Scler 2021;27:107-16. [DOI: 10.1177/1352458520958362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
17 Ziemssen T, Schulze-Topphoff U. The Change of Fingolimod Patient Profiles over Time: A Descriptive Analysis of Two Non-Interventional Studies PANGAEA and PANGAEA 2.0. J Pers Med 2021;11:561. [PMID: 34208513 DOI: 10.3390/jpm11060561] [Reference Citation Analysis]
18 Raats J, Lamers I, Baert I, Willekens B, Veldkamp R, Feys P. Cognitive-motor interference in persons with multiple sclerosis during five upper limb motor tasks with different complexity. Mult Scler 2019;25:1736-45. [PMID: 30417718 DOI: 10.1177/1352458518808194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
19 Orr J, Bernstein CN, Graff LA, Patten SB, Bolton JM, Sareen J, Marriott JJ, Fisk JD, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease. Factors associated with perceived need for mental health care in multiple sclerosis. Mult Scler Relat Disord 2018;25:179-85. [PMID: 30096684 DOI: 10.1016/j.msard.2018.07.043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Matias-Guiu JA, Cortés-Martínez A, Valles-Salgado M, Oreja-Guevara C, Pytel V, Montero P, Moreno-Ramos T, Matias-Guiu J. Functional Components of Cognitive Impairment in Multiple Sclerosis: A Cross-Sectional Investigation. Front Neurol 2017;8:643. [PMID: 29234305 DOI: 10.3389/fneur.2017.00643] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
21 Carotenuto A, Costabile T, Pontillo G, Moccia M, Falco F, Petracca M, Petruzzo M, Russo CV, Di Stasi M, Paolella C, Perillo T, Vola EA, Cipullo MB, Cocozza S, Lanzillo R, Brescia Morra V, Saccà F. Cognitive trajectories in multiple sclerosis: a long-term follow-up study. Neurol Sci 2021. [PMID: 34105018 DOI: 10.1007/s10072-021-05356-2] [Reference Citation Analysis]
22 Kuceyeski A, Monohan E, Morris E, Fujimoto K, Vargas W, Gauthier SA. Baseline biomarkers of connectome disruption and atrophy predict future processing speed in early multiple sclerosis. Neuroimage Clin 2018;19:417-24. [PMID: 30013921 DOI: 10.1016/j.nicl.2018.05.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
23 Schmidt SL, Santos da Silva M, Schmidt JJ, Carvalho ALN, Vasconcelos CCF, Paes RA, Boechat YE, Neder R, Alvarenga RP. Neuropsychiatric assessments in patients with multiple sclerosis in early phases and with low disability. Neuropsychiatr Dis Treat 2018;14:1665-70. [PMID: 29950848 DOI: 10.2147/NDT.S163480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Langeskov-Christensen M, Hvid LG, Jensen HB, Nielsen HH, Petersen T, Stenager E, Hämäläinen P, Dalgas U. Efficacy of high-intensity aerobic exercise on cognitive performance in people with multiple sclerosis: A randomized controlled trial. Mult Scler 2021;27:1585-96. [PMID: 33232191 DOI: 10.1177/1352458520973619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Garcia-Gorro C, Llera A, Martinez-Horta S, Perez-Perez J, Kulisevsky J, Rodriguez-Dechicha N, Vaquer I, Subira S, Calopa M, Muñoz E, Santacruz P, Ruiz-Idiago J, Mareca C, Beckmann CF, de Diego-Balaguer R, Camara E. Specific patterns of brain alterations underlie distinct clinical profiles in Huntington's disease. Neuroimage Clin 2019;23:101900. [PMID: 31255947 DOI: 10.1016/j.nicl.2019.101900] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
26 Colato E, Stutters J, Tur C, Narayanan S, Arnold DL, Gandini Wheeler-Kingshott CAM, Barkhof F, Ciccarelli O, Chard DT, Eshaghi A. Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes. J Neurol Neurosurg Psychiatry 2021;92:995-1006. [PMID: 33879535 DOI: 10.1136/jnnp-2020-325610] [Reference Citation Analysis]
27 Simmons SB, Schippling S, Giovannoni G, Ontaneda D. Predicting disability worsening in relapsing and progressive multiple sclerosis. Curr Opin Neurol 2021;34:312-21. [PMID: 33709974 DOI: 10.1097/WCO.0000000000000928] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 van der Hiele K, van Gorp DAM, van Egmond EEA, Jongen PJ, Reneman MF, van der Klink JJL, Arnoldus EPJ, Beenakker EAC, van Eijk JJJ, Frequin STFM, de Gans K, Hengstman GJD, Hoitsma E, Gerlach OHH, Verhagen WIM, Heerings MAP, Middelkoop HAM, Visser LH. Self-reported occupational functioning in persons with relapsing-remitting multiple sclerosis: Does personality matter? J Neurol Sci 2021;427:117561. [PMID: 34216973 DOI: 10.1016/j.jns.2021.117561] [Reference Citation Analysis]
29 Bergsland N, Benedict RHB, Dwyer MG, Fuchs TA, Jakimovski D, Schweser F, Tavazzi E, Weinstock-Guttman B, Zivadinov R. Thalamic Nuclei Volumes and Their Relationships to Neuroperformance in Multiple Sclerosis: A Cross-Sectional Structural MRI Study. J Magn Reson Imaging 2021;53:731-9. [PMID: 33044013 DOI: 10.1002/jmri.27389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Glick HA, Sharma A. Cortical Neuroplasticity and Cognitive Function in Early-Stage, Mild-Moderate Hearing Loss: Evidence of Neurocognitive Benefit From Hearing Aid Use. Front Neurosci 2020;14:93. [PMID: 32132893 DOI: 10.3389/fnins.2020.00093] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
31 Ruiu E, Dubbioso R, Madsen KH, Svolgaard O, Raffin E, Andersen KW, Karabanov AN, Siebner HR. Probing Context-Dependent Modulations of Ipsilateral Premotor-Motor Connectivity in Relapsing-Remitting Multiple Sclerosis. Front Neurol 2020;11:193. [PMID: 32431655 DOI: 10.3389/fneur.2020.00193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Bsteh G, Hegen H, Altmann P, Auer M, Berek K, Di Pauli F, Leutmezer F, Rommer P, Wurth S, Zinganell A, Zrzavy T, Deisenhammer F, Berger T. Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis. Eur J Neurol 2021;28:2037-45. [PMID: 33735479 DOI: 10.1111/ene.14829] [Reference Citation Analysis]
33 Blair M, Goveas D, Safi A, Marshall C, Rosehart H, Orenczuk S, Morrow SA. Does cognitive training improve attention/working memory in persons with MS? A pilot study using the Cogmed Working Memory Training program. Mult Scler Relat Disord 2021;49:102770. [PMID: 33497850 DOI: 10.1016/j.msard.2021.102770] [Reference Citation Analysis]
34 Rieckmann P, Schwab M, Pöhlau D, Penner I, Wagner T, Schel E, Bayas A. Adherence to Subcutaneous IFN β-1a in Multiple Sclerosis: Final Analysis of the Non-Interventional Study READOUTsmart Using the Dosing Log and Readout Function of RebiSmart®. Adv Ther 2019;36:175-86. [DOI: 10.1007/s12325-018-0839-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Shaw MT, Palmeri MJ, Malik M, Dobbs B, Charvet LE. Virtual reality is a feasible intervention platform in multiple sclerosis: A pilot protocol and acute improvements in affect. Mult Scler J Exp Transl Clin 2021;7:20552173211006139. [PMID: 33889420 DOI: 10.1177/20552173211006139] [Reference Citation Analysis]
36 Healy BC, Barker L, Bakshi R, Benedict RHB, Gonzalez CT, Chitnis T, Weiner HL, Glanz BI. Trajectories of Symbol Digit Modalities Test performance in individuals with multiple sclerosis. Mult Scler 2021;27:593-602. [DOI: 10.1177/1352458520913439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
37 Galioto R, Macaron G, Lace JW, Ontaneda D, Rao SM. Is computerized screening for processing speed impairment sufficient for identifying MS-related cognitive impairment in a clinical setting? Mult Scler Relat Disord 2021;54:103106. [PMID: 34217998 DOI: 10.1016/j.msard.2021.103106] [Reference Citation Analysis]
38 Mędrzycka-Dąbrowska WA, Czyż-Szybenbejl K, Kwiecień-Jaguś K, Lewandowska K. Prediction of cognitive dysfunction after resuscitation - a systematic review. Postepy Kardiol Interwencyjnej 2018;14:225-32. [PMID: 30302097 DOI: 10.5114/aic.2018.78324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
39 Guevara C, Villa E, Diaz V, Garrido C, Martinez M, Orellana P, Alarcón P, Silva-Rosas C, Barker GJ, Kempton MJ, de Grazia J. Inclusion of the Symbol Digit Modalities Test in a revised assessment of 'no evidence of disease activity-4 (NEDA-4)' in Latin-American patients with multiple sclerosis. Mult Scler Relat Disord 2020;42:102076. [PMID: 32361478 DOI: 10.1016/j.msard.2020.102076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Sandroff BM, Diggs MD, Bamman MM, Cutter GR, Baird JF, Jones CD, Rinker JR, Wylie GR, DeLuca J, Motl RW. Protocol for a systematically-developed, phase I/II, single-blind randomized controlled trial of treadmill walking exercise training effects on cognition and brain function in persons with multiple sclerosis. Contemp Clin Trials 2019;87:105878. [PMID: 31704437 DOI: 10.1016/j.cct.2019.105878] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
41 Jaworski MG, Fuchs TA, Dwyer MG, Wojcik C, Zivadinov R, Weinstock-guttman B, Benedict RH. Conscientiousness and deterioration in employment status in multiple sclerosis over 3 years. Mult Scler 2021;27:1125-35. [DOI: 10.1177/1352458520946019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Kahraman T, Savci S, Ozdogar AT, Gedik Z, Idiman E. Physical, cognitive and psychosocial effects of telerehabilitation-based motor imagery training in people with multiple sclerosis: A randomized controlled pilot trial. J Telemed Telecare 2020;26:251-60. [PMID: 30744491 DOI: 10.1177/1357633X18822355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
43 Eilam-Stock T, Shaw MT, Krupp LB, Charvet LE. Early neuropsychological markers of cognitive involvement in multiple sclerosis. J Neurol Sci 2021;423:117349. [PMID: 33639421 DOI: 10.1016/j.jns.2021.117349] [Reference Citation Analysis]
44 Riccardi A, Ognibene F, Mondini S, Nucci M, Margoni M, Meglioranzi I, Carta E, Zywicki S, Miante S, Perini P, Rinaldi F, Puthenparampil M, Gallo P. Designing a Self-Perception Cognitive Questionnaire for Italian Multiple Sclerosis Patients (Sclerosi Multipla Autovalutazione Cognitiva, SMAC). A Preliminary Exploratory Pilot Study. Front Neurol 2021;12:668933. [PMID: 34262521 DOI: 10.3389/fneur.2021.668933] [Reference Citation Analysis]
45 Bove R, Rowles W, Zhao C, Anderson A, Friedman S, Langdon D, Alexander A, Sacco S, Henry R, Gazzaley A, Feinstein A, Anguera JA. A novel in-home digital treatment to improve processing speed in people with multiple sclerosis: A pilot study. Mult Scler 2021;27:778-89. [PMID: 32584155 DOI: 10.1177/1352458520930371] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
46 D'hooghe MB, Gielen J, Van Remoortel A, D'haeseleer M, Peeters E, Cambron M, De Keyser J, Nagels G. Single MRI-Based Volumetric Assessment in Clinical Practice Is Associated With MS-Related Disability: MRI Brain Volume and MS Disability. J Magn Reson Imaging 2019;49:1312-21. [DOI: 10.1002/jmri.26303] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
47 Joly H, Cohen M, Bresch S, Lebrun-frenay C. Impact of executive dysfunction on naming ability in multiple sclerosis. Revue Neurologique 2019;175:552-9. [DOI: 10.1016/j.neurol.2019.02.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Riccitelli GC, Pagani E, Rodegher M, Colombo B, Preziosa P, Falini A, Comi G, Filippi M, Rocca MA. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis. Mult Scler 2019;25:204-16. [DOI: 10.1177/1352458517743091] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
49 Keune PM, Hansen S, Sauder T, Jaruszowic S, Kehm C, Keune J, Weber E, Schönenberg M, Oschmann P. Frontal brain activity and cognitive processing speed in multiple sclerosis: An exploration of EEG neurofeedback training. Neuroimage Clin 2019;22:101716. [PMID: 30798167 DOI: 10.1016/j.nicl.2019.101716] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
50 Healy BC, Glanz BI, Swallow E, Signorovitch J, Hagan K, Silva D, Pelletier C, Chitnis T, Weiner H. Confirmed disability progression provides limited predictive information regarding future disease progression in multiple sclerosis. Mult Scler J Exp Transl Clin 2021;7:2055217321999070. [PMID: 33953937 DOI: 10.1177/2055217321999070] [Reference Citation Analysis]
51 Riemenschneider M, Hvid LG, Ringgaard S, Nygaard MKE, Eskildsen SF, Petersen T, Stenager E, Dalgas U. Study protocol: randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: the Early Multiple Sclerosis Exercise Study (EMSES). BMJ Open 2021;11:e043699. [PMID: 33436475 DOI: 10.1136/bmjopen-2020-043699] [Reference Citation Analysis]
52 Patel VP, Feinstein A. The link between depression and performance on the Symbol Digit Modalities Test: Mechanisms and clinical significance. Mult Scler 2019;25:118-21. [DOI: 10.1177/1352458518770086] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
53 Petrou P, Ginzberg A, Binyamin O, Karussis D. Beneficial effects of a nano formulation of pomegranate seed oil, GranaGard, on the cognitive function of multiple sclerosis patients. Mult Scler Relat Disord 2021;54:103103. [PMID: 34243101 DOI: 10.1016/j.msard.2021.103103] [Reference Citation Analysis]
54 Bergsland N, Schweser F, Dwyer MG, Weinstock-Guttman B, Benedict RHB, Zivadinov R. Thalamic white matter in multiple sclerosis: A combined diffusion-tensor imaging and quantitative susceptibility mapping study. Hum Brain Mapp 2018;39:4007-17. [PMID: 29923266 DOI: 10.1002/hbm.24227] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
55 Cohen JN, Seng E, Foley FW. Cognitive and motor slowing mediate the relationship between depression and falls in multiple sclerosis patients. Mult Scler Relat Disord 2021;50:102808. [PMID: 33596493 DOI: 10.1016/j.msard.2021.102808] [Reference Citation Analysis]
56 Niino M, Fukazawa T, Kira JI, Okuno T, Mori M, Sanjo N, Ohashi T, Fukaura H, Fujimori J, Shimizu Y, Mifune N, Miyazaki Y, Takahashi E, Kikuchi S, Langdon D, Hb Benedict R, Matsui M. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan. Mult Scler J Exp Transl Clin 2017;3:2055217317748972. [PMID: 29339837 DOI: 10.1177/2055217317748972] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
57 Eijlers AJC, van Geest Q, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Barkhof F, Uitdehaag BMJ, Schoonheim MM, Geurts JJG. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study. Brain 2018;141:2605-18. [PMID: 30169585 DOI: 10.1093/brain/awy202] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
58 Weinstock-guttman B, Eckert S, Benedict RH. A decline in cognitive function should lead to a change in disease-modifying therapy – Yes. Mult Scler 2018;24:1681-2. [DOI: 10.1177/1352458518783364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
59 Nigri A, Sarro L, Mongelli A, Castaldo A, Porcu L, Pinardi C, Grisoli M, Ferraro S, Canafoglia L, Visani E, Bruzzone MG, Nanetti L, Taroni F, Mariotti C. Spinocerebellar Ataxia Type 1: One-Year Longitudinal Study to Identify Clinical and MRI Measures of Disease Progression in Patients and Presymptomatic Carriers. Cerebellum 2021. [PMID: 34106418 DOI: 10.1007/s12311-021-01285-0] [Reference Citation Analysis]
60 Zainal NH, Newman MG. Larger increase in trait negative affect is associated with greater future cognitive decline and vice versa across 23 years. Depress Anxiety 2021;38:146-60. [PMID: 32840954 DOI: 10.1002/da.23093] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
61 Rose AF, Gilbertson AF, Cottrell C, Tampi RR. Cognitive screening for adult psychiatric outpatients: Comparison of the Cognivue® to the Montreal Cognitive Assessment. World J Psychiatry 2021;11:265-70. [PMID: 34327120 DOI: 10.5498/wjp.v11.i7.265] [Reference Citation Analysis]
62 Chaves AR, Snow NJ, Alcock LR, Ploughman M. Probing the Brain-Body Connection Using Transcranial Magnetic Stimulation (TMS): Validating a Promising Tool to Provide Biomarkers of Neuroplasticity and Central Nervous System Function. Brain Sci 2021;11:384. [PMID: 33803028 DOI: 10.3390/brainsci11030384] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 van Gorp DAM, van der Klink JJL, Abma FI, Jongen PJ, van Lieshout I, Arnoldus EPJ, Beenakker EAC, Bos HM, van Eijk JJJ, Fermont J, Frequin STFM, de Gans K, Hengstman GJD, Hupperts RMM, Mostert JP, Pop PHM, Verhagen WIM, Zemel D, Heerings MAP, Reneman MF, Middelkoop HAM, Visser LH, van der Hiele K. The capability set for work - correlates of sustainable employability in workers with multiple sclerosis. Health Qual Life Outcomes 2018;16:113. [PMID: 29859113 DOI: 10.1186/s12955-018-0942-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
64 Kalb R, Beier M, Benedict RH, Charvet L, Costello K, Feinstein A, Gingold J, Goverover Y, Halper J, Harris C, Kostich L, Krupp L, Lathi E, LaRocca N, Thrower B, DeLuca J. Recommendations for cognitive screening and management in multiple sclerosis care. Mult Scler 2018;24:1665-80. [PMID: 30303036 DOI: 10.1177/1352458518803785] [Cited by in Crossref: 104] [Cited by in F6Publishing: 61] [Article Influence: 34.7] [Reference Citation Analysis]
65 Lakin L, Davis BE, Binns CC, Currie KM, Rensel MR. Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms-A Narrative Review. Neurol Ther 2021;10:75-98. [PMID: 33877583 DOI: 10.1007/s40120-021-00239-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
66 Di Filippo M, Portaccio E, Mancini A, Calabresi P. Multiple sclerosis and cognition: synaptic failure and network dysfunction. Nat Rev Neurosci 2018;19:599-609. [PMID: 30158590 DOI: 10.1038/s41583-018-0053-9] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 36.0] [Reference Citation Analysis]
67 Benedict RHB, Tomic D, Cree BA, Fox R, Giovannoni G, Bar-Or A, Gold R, Vermersch P, Pohlmann H, Wright I, Karlsson G, Dahlke F, Wolf C, Kappos L. Siponimod and Cognition in Secondary Progressive Multiple Sclerosis: EXPAND Secondary Analyses. Neurology 2021;96:e376-86. [PMID: 33328324 DOI: 10.1212/WNL.0000000000011275] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
68 Johnen A, Bürkner PC, Landmeyer NC, Ambrosius B, Calabrese P, Motte J, Hessler N, Antony G, König IR, Klotz L, Hoshi MM, Aly L, Groppa S, Luessi F, Paul F, Tackenberg B, Bergh FT, Kümpfel T, Tumani H, Stangel M, Weber F, Bayas A, Wildemann B, Heesen C, Zettl UK, Zipp F, Hemmer B, Meuth SG, Gold R, Wiendl H, Salmen A; German Competence Network Multiple Sclerosis (KKNMS). Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS). J Neurol 2019;266:386-97. [PMID: 30515631 DOI: 10.1007/s00415-018-9142-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
69 Patel VP, Shen L, Rose J, Feinstein A. Taking the tester out of the SDMT: A proof of concept fully automated approach to assessing processing speed in people with MS. Mult Scler 2019;25:1506-13. [DOI: 10.1177/1352458518792772] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
70 Shibata S, Takemura M, Miyakawa S. The influence of differences in neurocognitive function on lower limb kinematics, kinetics, and muscle activity during an unanticipated cutting motion. Phys Ther Res 2018;21:44-52. [PMID: 30697509 DOI: 10.1298/ptr.E9938] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
71 Hansen S, Lautenbacher S. Neuropsychological Assessment in Multiple Sclerosis: An Overview. Zeitschrift für Neuropsychologie 2017;28:117-48. [DOI: 10.1024/1016-264x/a000197] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
72 Conradsson D, Ytterberg C, von Koch L, Johansson S. Changes in disability in people with multiple sclerosis: a 10-year prospective study. J Neurol 2018;265:119-26. [PMID: 29159465 DOI: 10.1007/s00415-017-8676-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
73 Aitkenhead L, Krishna G, Ellerton C, Moinuddin M, Matcham J, Shiel L, Hossain S, Kiffin M, Foley J, Skeath R, Cleary M, Lachmann R, Murphy E. Long-term cognitive and psychosocial outcomes in adults with phenylketonuria. J Inherit Metab Dis 2021. [PMID: 34145605 DOI: 10.1002/jimd.12413] [Reference Citation Analysis]
74 Genova HM, Lancaster K, Lengenfelder J, Bober CP, Deluca J, Chiaravalloti ND. Relationship between social cognition and fatigue, depressive symptoms, and anxiety in multiple sclerosis. J Neuropsychol 2020;14:213-25. [DOI: 10.1111/jnp.12185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
75 Chaves AR, Wallack EM, Kelly LP, Pretty RW, Wiseman HD, Chen A, Moore CS, Stefanelli M, Ploughman M. Asymmetry of Brain Excitability: A New Biomarker that Predicts Objective and Subjective Symptoms in Multiple Sclerosis. Behavioural Brain Research 2019;359:281-91. [DOI: 10.1016/j.bbr.2018.11.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
76 Migliore S, Landi D, Proietti F, D'Aurizio G, Squitieri F, Mataluni G, Nicoletti CG, Curcio G, Marfia GA. Validity of the Italian multiple sclerosis neuropsychological screening questionnaire. Neurol Sci 2021. [PMID: 33651198 DOI: 10.1007/s10072-021-05141-1] [Reference Citation Analysis]
77 Chen MH, Goverover Y, Genova HM, DeLuca J. Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review. CNS Drugs 2020;34:599-628. [PMID: 32361940 DOI: 10.1007/s40263-020-00734-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
78 Lanzillo R, Sparaco M, Lavorgna L, Carmisciano L, Signoriello E, Signori A, Costabile T, Maniscalco GT, Saccà F, Cepparulo S, Russo CV, Bisecco A, Frattaruolo N, Strianese A, Lus G, Brescia Morra V, Bonavita S. A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting. Neurol Sci 2020;41:3235-41. [PMID: 32388646 DOI: 10.1007/s10072-020-04367-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Bonzano L, Pedullà L, Pardini M, Tacchino A, Zaratin P, Battaglia MA, Brichetto G, Bove M. Brain activity pattern changes after adaptive working memory training in multiple sclerosis. Brain Imaging Behav 2020;14:142-54. [PMID: 30377931 DOI: 10.1007/s11682-018-9984-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
80 D'hooghe MB, De Cock A, Van Remoortel A, Benedict RHB, Eelen P, Peeters E, D'haeseleer M, De Keyser J, Nagels G. Correlations of health status indicators with perceived neuropsychological impairment and cognitive processing speed in multiple sclerosis. Multiple Sclerosis and Related Disorders 2020;39:101904. [DOI: 10.1016/j.msard.2019.101904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Hämäläinen P, Leo V, Therman S, Ruutiainen J. Validation of the Finnish version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and evaluation of the applicability of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) and the Fatigue Scale for Motor and Cognitive Functions (FSMC). Brain Behav 2021;11:e02087. [PMID: 33960700 DOI: 10.1002/brb3.2087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Barois E, Sagawa Y, Yilmaz S, Magnin E, Decavel P. What (more) can verbal fluency tell us about multiple sclerosis? Ann Phys Rehabil Med 2021;64:101394. [PMID: 32450272 DOI: 10.1016/j.rehab.2020.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Krysko KM, Bischof A, Nourbakhsh B, Henry RG, Revirajan N, Manguinao M, Nguyen K, Akula A, Li Y, Waubant E. A pilot study of oxidative pathways in MS fatigue: randomized trial of N-acetyl cysteine. Ann Clin Transl Neurol 2021;8:811-24. [PMID: 33675156 DOI: 10.1002/acn3.51325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Macías Islas MÁ, Ciampi E. Assessment and Impact of Cognitive Impairment in Multiple Sclerosis: An Overview. Biomedicines 2019;7:E22. [PMID: 30893874 DOI: 10.3390/biomedicines7010022] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 12.5] [Reference Citation Analysis]
85 Baetge SJ, Filser M, Renner A, Ullrich S, Lassek C, Penner I. On the validity of single tests, two-test combinations and the full Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in detecting patients with cognitive impairment. Mult Scler 2020;26:1919-28. [DOI: 10.1177/1352458519887897] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
86 Vanotti S, Smerbeck A, Eizaguirre MB, Saladino ML, Benedict RRH, Caceres FJ. BICAMS in the Argentine population: Relationship with clinical and sociodemographic variables. Appl Neuropsychol Adult 2018;25:424-33. [PMID: 28534643 DOI: 10.1080/23279095.2017.1323751] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
87 Wojcik CM, Beier M, Costello K, DeLuca J, Feinstein A, Goverover Y, Gudesblatt M, Jaworski M 3rd, Kalb R, Kostich L, LaRocca NG, Rodgers JD, Benedict RH; National MS Society Cognition Work Team. Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review. Mult Scler 2019;25:1848-69. [PMID: 31637963 DOI: 10.1177/1352458519879094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
88 Lu L, Chen L, Wu W, Wang Y, Liu Z, Xu J, Yang Q, Zhao J, Liu L, Yu H. Consistency and applicability of different brief screen instrument of cognitive function in elderly population. BMC Neurol 2021;21:95. [PMID: 33648444 DOI: 10.1186/s12883-021-02048-4] [Reference Citation Analysis]
89 Skorve E, Lundervold AJ, Torkildsen Ø, Myhr KM. The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler Relat Disord 2019;36:101408. [PMID: 31610403 DOI: 10.1016/j.msard.2019.101408] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
90 Okada K, Kakeda S, Tahara M. Olfactory identification associates with cognitive function and the third ventricle width in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders 2020;38:101507. [DOI: 10.1016/j.msard.2019.101507] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
91 Linortner P, McDaniel C, Shahid M, Levine TF, Tian L, Cholerton B, Poston KL. White Matter Hyperintensities Related to Parkinson's Disease Executive Function. Mov Disord Clin Pract 2020;7:629-38. [PMID: 32775508 DOI: 10.1002/mdc3.12956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
92 Giedraitiene N, Drukteiniene E, Kizlaitiene R, Cimbalas A, Asoklis R, Kaubrys G. Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study. Front Neurol 2021;12:678735. [PMID: 34326806 DOI: 10.3389/fneur.2021.678735] [Reference Citation Analysis]
93 De Meijer L, Merlo D, Skibina O, Grobbee EJ, Gale J, Haartsen J, Maruff P, Darby D, Butzkueven H, Van der Walt A. Monitoring cognitive change in multiple sclerosis using a computerized cognitive battery. Mult Scler J Exp Transl Clin 2018;4:2055217318815513. [PMID: 30559973 DOI: 10.1177/2055217318815513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
94 Ysrraelit MC, Fiol MP, Peña FV, Vanotti S, Terrasa SA, Tran VT, Montori VM, Correale J. Adaptation and validation of a Spanish version of the treatment burden questionnaire in patients with multiple sclerosis. BMC Neurol 2019;19:209. [PMID: 31455235 DOI: 10.1186/s12883-019-1441-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
95 De Giglio L, De Luca F, Gurreri F, Ferrante I, Prosperini L, Borriello G, Quartuccio E, Gasperini C, Pozzilli C. Effect of dalfampridine on information processing speed impairment in multiple sclerosis. Neurology 2019;93:e733-46. [DOI: 10.1212/wnl.0000000000007970] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 7.5] [Reference Citation Analysis]
96 Macaron G, Feng J, Moodley M, Rensel M. Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis. Curr Treat Options Neurol 2019;21:50. [PMID: 31560095 DOI: 10.1007/s11940-019-0592-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
97 Fuchs TA, Wojcik C, Wilding GE, Pol J, Dwyer MG, Weinstock-Guttman B, Zivadinov R, Benedict RH. Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosis. Mult Scler 2020;26:245-52. [PMID: 30615562 DOI: 10.1177/1352458518820272] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
98 Fuchs TA, Benedict RHB, Bartnik A, Choudhery S, Li X, Mallory M, Oship D, Yasin F, Ashton K, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Zivadinov R, Dwyer MG. Preserved network functional connectivity underlies cognitive reserve in multiple sclerosis. Hum Brain Mapp 2019;40:5231-41. [PMID: 31444887 DOI: 10.1002/hbm.24768] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
99 Perumal J, Fox RJ, Balabanov R, Balcer LJ, Galetta S, Makh S, Santra S, Hotermans C, Lee L. Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE. BMC Neurol 2019;19:116. [PMID: 31176355 DOI: 10.1186/s12883-019-1337-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
100 Grigorescu C, Chalah MA, Lefaucheur JP, Kümpfel T, Padberg F, Ayache SS, Palm U. Effects of Transcranial Direct Current Stimulation on Information Processing Speed, Working Memory, Attention, and Social Cognition in Multiple Sclerosis. Front Neurol 2020;11:545377. [PMID: 33178103 DOI: 10.3389/fneur.2020.545377] [Reference Citation Analysis]
101 Snow NJ, Wadden KP, Chaves AR, Ploughman M. Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research. Neural Plast 2019;2019:6430596. [PMID: 31636661 DOI: 10.1155/2019/6430596] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
102 Bove RM, Rush G, Zhao C, Rowles W, Garcha P, Morrissey J, Schembri A, Alailima T, Langdon D, Possin K, Gazzaley A, Feinstein A, Anguera J. A Videogame-Based Digital Therapeutic to Improve Processing Speed in People with Multiple Sclerosis: A Feasibility Study. Neurol Ther 2019;8:135-45. [PMID: 30506301 DOI: 10.1007/s40120-018-0121-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
103 Pozzilli C, Prosperini L, Tommasin S, Gasperini C, Barbuti E, De Giglio L. Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trial. Ther Adv Neurol Disord 2021;14:17562864211011286. [PMID: 34035835 DOI: 10.1177/17562864211011286] [Reference Citation Analysis]
104 Linker RA, Chan A. Navigating choice in multiple sclerosis management. Neurol Res Pract 2019;1:5. [PMID: 33324871 DOI: 10.1186/s42466-019-0005-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
105 Pitteri M, Dapor C, Ziccardi S, Guandalini M, Meggiato R, Calabrese M. A Videogame-Based Approach to Measuring Information Processing Speed in Multiple Sclerosis Patients. Games Health J 2021;10:115-20. [PMID: 33818136 DOI: 10.1089/g4h.2020.0069] [Reference Citation Analysis]
106 Sandry J, Zuppichini M, Rothberg J, Valdespino-hayden Z, Deluca J. Poor Encoding and Weak Early Consolidation Underlie Memory Acquisition Deficits in Multiple Sclerosis: Retroactive Interference, Processing Speed, or Working Memory? Archives of Clinical Neuropsychology 2019;34:162-82. [DOI: 10.1093/arclin/acy029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
107 Shaw MT, Best P, Frontario A, Charvet LE. Telerehabilitation benefits patients with multiple sclerosis in an urban setting. J Telemed Telecare 2021;27:39-45. [PMID: 31307269 DOI: 10.1177/1357633X19861830] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
108 Feinstein A, Amato MP, Brichetto G, Chataway J, Chiaravalloti N, Dalgas U, DeLuca J, Feys P, Filippi M, Freeman J, Meza C, Inglese M, Motl RW, Rocca MA, Sandroff BM, Salter A, Cutter G; CogEx Research Team. Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx). BMC Neurol 2020;20:204. [PMID: 32443981 DOI: 10.1186/s12883-020-01772-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
109 Rhodes JK, Schindler D, Rao SM, Venegas F, Bruzik ET, Gabel W, Williams JR, Phillips GA, Mullen CC, Freiburger JL, Mourany L, Reece C, Miller DM, Bethoux F, Bermel RA, Krupp LB, Mowry EM, Alberts J, Rudick RA. Multiple Sclerosis Performance Test: Technical Development and Usability. Adv Ther 2019;36:1741-55. [PMID: 31054035 DOI: 10.1007/s12325-019-00958-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
110 Galioto R, Conway DS, Planchon SM, Rao SM. Is Obesity Related to Processing Speed Impairment in Patients with Multiple Sclerosis: Results of a Large-Scale, Multicenter Study. Archives of Clinical Neuropsychology 2020;35:506-10. [DOI: 10.1093/arclin/acaa003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Riepl E, Pfeuffer S, Ruck T, Lohmann H, Wiendl H, Meuth SG, Johnen A. Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis-A Longitudinal Observational Study. Front Neurol 2017;8:730. [PMID: 29387035 DOI: 10.3389/fneur.2017.00730] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
112 Merlo D, Darby D, Kalincik T, Butzkueven H, van der Walt A. The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis. Ther Adv Neurol Disord 2019;12:1756286419859183. [PMID: 31320932 DOI: 10.1177/1756286419859183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
113 Fu X, Lu Z, Wang Y, Huang L, Wang X, Zhang H, Xiao Z. A Clinical Research Study of Cognitive Dysfunction and Affective Impairment after Isolated Brainstem Stroke. Front Aging Neurosci 2017;9:400. [PMID: 29311895 DOI: 10.3389/fnagi.2017.00400] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
114 Eijlers AJ, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Pouwels PJ, Uitdehaag BM, Barkhof F, Vrenken H, Schoonheim MM, Geurts JJ. Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis. Neurology 2019;93:e1348-59. [DOI: 10.1212/wnl.0000000000008198] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
115 Rao SM, Galioto R, Sokolowski M, McGinley M, Freiburger J, Weber M, Dey T, Mourany L, Schindler D, Reece C, Miller DM, Bethoux F, Bermel RA, Williams JR, Levitt N, Phillips GA, Rhodes JK, Alberts J, Rudick RA. Multiple Sclerosis Performance Test: validation of self-administered neuroperformance modules. Eur J Neurol 2020;27:878-86. [PMID: 32009276 DOI: 10.1111/ene.14162] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
116 Bsteh G, Berek K, Hegen H, Altmann P, Wurth S, Auer M, Zinganell A, Di Pauli F, Rommer P, Leutmezer F, Deisenhammer F, Berger T. Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis. Mult Scler 2021;27:684-94. [PMID: 32613912 DOI: 10.1177/1352458520935724] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
117 Pitteri M, Magliozzi R, Bajrami A, Camera V, Calabrese M. Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables. Expert Opin Pharmacother 2018;19:387-95. [PMID: 29397790 DOI: 10.1080/14656566.2018.1434143] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
118 Lavorgna L, Sparaco M, Esposito S, Motl RW, Gallo A, Bisecco A, Tedeschi G, Bonavita S. Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis. Multiple Sclerosis and Related Disorders 2017;18:173-6. [DOI: 10.1016/j.msard.2017.09.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
119 Prosperini L, Castelli L, De Giglio L, Bonanno V, Gasperini C, Pozzilli C. Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled Trial. Neurotherapeutics 2020;17:704-9. [PMID: 31820274 DOI: 10.1007/s13311-019-00813-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
120 Eiró LG, Ferreira MKM, Frazão DR, Aragão WAB, Souza-Rodrigues RD, Fagundes NCF, Maia LC, Lima RR. Lead exposure and its association with neurological damage: systematic review and meta-analysis. Environ Sci Pollut Res Int 2021;28:37001-15. [PMID: 34046839 DOI: 10.1007/s11356-021-13536-y] [Reference Citation Analysis]
121 Bsteh G, Hegen H, Altmann P, Auer M, Berek K, Pauli FD, Wurth S, Zinganell A, Rommer P, Deisenhammer F, Leutmezer F, Berger T. Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis. Mult Scler J Exp Transl Clin 2020;6:2055217320966344. [PMID: 33194221 DOI: 10.1177/2055217320966344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
122 Chiaravalloti ND, Goverover Y, Costa SL, DeLuca J. A Pilot Study Examining Speed of Processing Training (SPT) to Improve Processing Speed in Persons With Multiple Sclerosis. Front Neurol 2018;9:685. [PMID: 30210426 DOI: 10.3389/fneur.2018.00685] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
123 Dirks P, Zingler V, Leemhuis J, Berthold H, Hieke-Schulz S, Wormser D, Ziemssen T. Design of a non-interventional post-marketing study to assess the long-term safety and effectiveness of ocrelizumab in German real world multiple sclerosis cohorts - the CONFIDENCE study protocol. BMC Neurol 2020;20:95. [PMID: 32171264 DOI: 10.1186/s12883-020-01667-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
124 Galioto R, Berenholz O, Wang Z, Conway DS, Planchon SM, Rao SM. Does obesity exacerbate brain lesion volume and atrophy in patients with multiple sclerosis? Mult Scler Relat Disord 2020;46:102502. [PMID: 32932165 DOI: 10.1016/j.msard.2020.102502] [Reference Citation Analysis]
125 Wajda DA, Zanotto T, Sosnoff JJ. Influence of the environment on cognitive-motor interaction during walking in people living with and without multiple sclerosis. Gait & Posture 2020;82:20-5. [DOI: 10.1016/j.gaitpost.2020.08.118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
126 Tao Y, XueSong Z, Xiao Y, YueZhi K, Xin W, YanPing T, Lei W, YongPing F. Association between symbol digit modalities test and regional cortex thickness in young adults with relapsing-remitting multiple sclerosis. Clin Neurol Neurosurg 2021;207:106805. [PMID: 34280674 DOI: 10.1016/j.clineuro.2021.106805] [Reference Citation Analysis]
127 Johansson S, Ytterberg C, Gottberg K, Holmqvist LW, von Koch L, Conradsson D. Participation in social/lifestyle activities in people with multiple sclerosis: Changes across 10 years and predictors of sustained participation. Mult Scler 2020;26:1775-84. [DOI: 10.1177/1352458519881991] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
128 Macaron G, Ontaneda D. Diagnosis and Management of Progressive Multiple Sclerosis. Biomedicines 2019;7:E56. [PMID: 31362384 DOI: 10.3390/biomedicines7030056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
129 Chitnis T, Gonzalez C, Healy BC, Saxena S, Rosso M, Barro C, Michalak Z, Paul A, Kivisakk P, Diaz-Cruz C, Sattarnezhad N, Pierre IV, Glanz BI, Tomic D, Kropshofer H, Häring D, Leppert D, Kappos L, Bakshi R, Weiner HL, Kuhle J. Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis. Ann Clin Transl Neurol 2018;5:1478-91. [PMID: 30564615 DOI: 10.1002/acn3.638] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 18.7] [Reference Citation Analysis]
130 Benedict RH, Pol J, Yasin F, Hojnacki D, Kolb C, Eckert S, Tacca B, Drake A, Wojcik C, Morrow SA, Jakimovski D, Fuchs TA, Dwyer MG, Zivadinov R, Weinstock-Guttman B. Recovery of cognitive function after relapse in multiple sclerosis. Mult Scler 2021;27:71-8. [PMID: 31971066 DOI: 10.1177/1352458519898108] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
131 Fuchs TA, Ziccardi S, Benedict RHB, Bartnik A, Kuceyeski A, Charvet LE, Oship D, Weinstock-Guttman B, Wojcik C, Hojnacki D, Kolb C, Escobar J, Campbell R, Tran HD, Bergsland N, Jakimovski D, Zivadinov R, Dwyer MG. Functional Connectivity and Structural Disruption in the Default-Mode Network Predicts Cognitive Rehabilitation Outcomes in Multiple Sclerosis. J Neuroimaging 2020;30:523-30. [PMID: 32391981 DOI: 10.1111/jon.12723] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
132 Danneels M, Van Hecke R, Leyssens L, Degeest S, Cambier D, van de Berg R, Van Rompaey V, Maes L. 2BALANCE: a cognitive-motor dual-task protocol for individuals with vestibular dysfunction. BMJ Open 2020;10:e037138. [PMID: 32665391 DOI: 10.1136/bmjopen-2020-037138] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
133 Inojosa H, Proschmann U, Akgün K, Ziemssen T. Should We Use Clinical Tools to Identify Disease Progression? Front Neurol 2020;11:628542. [PMID: 33551982 DOI: 10.3389/fneur.2020.628542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
134 Uitdehaag BMJ. Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis. CNS Drugs 2018;32:543-58. [PMID: 29926371 DOI: 10.1007/s40263-018-0530-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
135 Czekóová K, Shaw DJ, Saxunová K, Dufek M, Mareček R, Vaníček J, Brázdil M. Impaired Self-Other Distinction and Subcortical Gray-Matter Alterations Characterize Socio-Cognitive Disturbances in Multiple Sclerosis. Front Neurol 2019;10:525. [PMID: 31164860 DOI: 10.3389/fneur.2019.00525] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
136 Mayo CD, Harrison L, Attwell-Pope K, Stuart-Hill L, Gawryluk JR. A pilot study of the impact of an exercise intervention on brain structure, cognition, and psychosocial symptoms in individuals with relapsing-remitting multiple sclerosis. Pilot Feasibility Stud 2021;7:65. [PMID: 33685527 DOI: 10.1186/s40814-021-00806-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Bollaert RE, Sandroff BM, Stine-Morrow EAL, Sutton BP, Motl RW. The Intersection of Physical Function, Cognitive Performance, Aging, and Multiple Sclerosis: A Cross-sectional Comparative Study. Cogn Behav Neurol 2019;32:1-10. [PMID: 30896571 DOI: 10.1097/WNN.0000000000000179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
138 Rasche L, Scheel M, Otte K, Althoff P, van Vuuren AB, Gieß RM, Kuchling J, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU, Schmitz-Hübsch T. MRI Markers and Functional Performance in Patients With CIS and MS: A Cross-Sectional Study. Front Neurol 2018;9:718. [PMID: 30210439 DOI: 10.3389/fneur.2018.00718] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
139 Andreasen AK, Iversen P, Marstrand L, Siersma V, Siebner HR, Sellebjerg F. Structural and cognitive correlates of fatigue in progressive multiple sclerosis. Neurol Res 2019;41:168-76. [PMID: 30513278 DOI: 10.1080/01616412.2018.1547813] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
140 Khan A, Li Y, Ponirakis G, Akhtar N, Gad H, George P, Ibrahim FM, Petropoulos IN, Canibano BG, Deleu D, Shuaib A, Kamran S, Malik RA. Corneal Immune Cells Are Increased in Patients With Multiple Sclerosis. Transl Vis Sci Technol 2021;10:19. [PMID: 34003997 DOI: 10.1167/tvst.10.4.19] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
141 Baird JF, Motl RW. Cognitive Function and Whole-Brain MRI Metrics Are Not Associated with Mobility in Older Adults with Multiple Sclerosis. Int J Environ Res Public Health 2021;18:4232. [PMID: 33923592 DOI: 10.3390/ijerph18084232] [Reference Citation Analysis]
142 Eizaguirre MB, Vanotti SI, Aguayo Arelis A, Rabago Barajas B, Cores EV, Macías MA, Benedict RHB, Cáceres F. Symbol Digit Modalities Test-Oral Version: An Analysis of Culture Influence on a Processing Speed Test in Argentina, Mexico, and the USA. Developmental Neuropsychology 2020;45:129-38. [DOI: 10.1080/87565641.2020.1737699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G. International consensus on quality standards for brain health-focused care in multiple sclerosis. Mult Scler 2019;25:1809-18. [PMID: 30381987 DOI: 10.1177/1352458518809326] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
144 Goldman MD, LaRocca NG, Rudick RA, Hudson LD, Chin PS, Francis GS, Jacobs A, Kapoor R, Matthews PM, Mowry EM, Balcer LJ, Panzara M, Phillips G, Uitdehaag BMJ, Cohen JA; Multiple Sclerosis Outcome Assessments Consortium. Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data. Neurology 2019;93:e1921-31. [PMID: 31641014 DOI: 10.1212/WNL.0000000000008519] [Cited by in Crossref: 25] [Cited by in F6Publishing: 3] [Article Influence: 12.5] [Reference Citation Analysis]
145 Meijer KA, van Geest Q, Eijlers AJC, Geurts JJG, Schoonheim MM, Hulst HE. Is impaired information processing speed a matter of structural or functional damage in MS? Neuroimage Clin 2018;20:844-50. [PMID: 30278371 DOI: 10.1016/j.nicl.2018.09.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
146 Cree BAC, Arnold DL, Chataway J, Chitnis T, Fox RJ, Pozo Ramajo A, Murphy N, Lassmann H. Secondary Progressive Multiple Sclerosis: New Insights. Neurology 2021;97:378-88. [PMID: 34088878 DOI: 10.1212/WNL.0000000000012323] [Reference Citation Analysis]
147 Gaetani L, Salvadori N, Chipi E, Gentili L, Borrelli A, Parnetti L, Di Filippo M. Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers. Neural Regen Res 2021;16:36-42. [PMID: 32788445 DOI: 10.4103/1673-5374.286949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Turtola ZP, Covey TJ. Working memory training impacts neural activity during untrained cognitive tasks in people with multiple sclerosis. Exp Neurol 2021;335:113487. [PMID: 32991935 DOI: 10.1016/j.expneurol.2020.113487] [Reference Citation Analysis]
149 LaRocca NG, Hudson LD, Rudick R, Amtmann D, Balcer L, Benedict R, Bermel R, Chang I, Chiaravalloti ND, Chin P, Cohen JA, Cutter GR, Davis MD, DeLuca J, Feys P, Francis G, Goldman MD, Hartley E, Kapoor R, Lublin F, Lundstrom G, Matthews PM, Mayo N, Meibach R, Miller DM, Motl RW, Mowry EM, Naismith R, Neville J, Panagoulias J, Panzara M, Phillips G, Robbins A, Sidovar MF, Smith KE, Sperling B, Uitdehaag BM, Weaver J; Multiple Sclerosis Outcome Assessments Consortium (MSOAC). The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability. Mult Scler 2018;24:1469-84. [PMID: 28799444 DOI: 10.1177/1352458517723718] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
150 Orban A, Garg B, Sammi MK, Bourdette DN, Rooney WD, Kuehl K, Spain RI. Effect of High-Intensity Exercise on Multiple Sclerosis Function and Phosphorous Magnetic Resonance Spectroscopy Outcomes. Med Sci Sports Exerc 2019;51:1380-6. [PMID: 31205251 DOI: 10.1249/MSS.0000000000001914] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
151 Ruet A, Brochet B. Cognitive assessment in patients with multiple sclerosis: From neuropsychological batteries to ecological tools. Annals of Physical and Rehabilitation Medicine 2020;63:154-8. [DOI: 10.1016/j.rehab.2018.01.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
152 Freedman MS, Devonshire V, Duquette P, Giacomini PS, Giuliani F, Levin MC, Montalban X, Morrow SA, Oh J, Rotstein D, Yeh EA. Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations. Can J Neurol Sci 2020;47:437-55. [DOI: 10.1017/cjn.2020.66] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
153 Goverover Y, Genova HM, Smith A, Lengenfelder J, Chiaravalloti ND. Changes in Activity Participation After Multiple Sclerosis Diagnosis. Int J MS Care 2020;22:23-30. [PMID: 32123525 DOI: 10.7224/1537-2073.2018-036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
154 Silva PHR, Spedo CT, Barreira AA, Leoni RF. Symbol Digit Modalities Test adaptation for Magnetic Resonance Imaging environment: A systematic review and meta-analysis. Mult Scler Relat Disord 2018;20:136-43. [PMID: 29414287 DOI: 10.1016/j.msard.2018.01.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
155 Ritland BM, Simonelli G, Gentili RJ, Smith JC, He X, Oh H, Balkin TJ, Hatfield BD. Sleep health and its association with performance and motivation in tactical athletes enrolled in the Reserve Officers' Training Corps. Sleep Health 2019;5:309-14. [DOI: 10.1016/j.sleh.2019.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
156 Povolo CA, Blair M, Mehta S, Rosehart H, Morrow SA. Predictors of vocational status among persons with multiple sclerosis. Mult Scler Relat Disord 2019;36:101411. [PMID: 31586801 DOI: 10.1016/j.msard.2019.101411] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
157 Jaeger J. Digit Symbol Substitution Test: The Case for Sensitivity Over Specificity in Neuropsychological Testing. J Clin Psychopharmacol 2018;38:513-9. [PMID: 30124583 DOI: 10.1097/JCP.0000000000000941] [Cited by in Crossref: 107] [Cited by in F6Publishing: 46] [Article Influence: 35.7] [Reference Citation Analysis]
158 Amezcua L, Smith JB, Gonzales EG, Haraszti S, Langer-Gould A. Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis. Neurology 2020;94:e1548-56. [PMID: 32152131 DOI: 10.1212/WNL.0000000000009210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
159 DeLuca J, Schippling S, Montalban X, Kappos L, Cree BAC, Comi G, Arnold DL, Hartung HP, Sheffield JK, Liu H, Silva D, Cohen JA. Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS. Mult Scler Relat Disord 2021;48:102673. [PMID: 33454584 DOI: 10.1016/j.msard.2020.102673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
160 Jacobsen C, Zivadinov R, Myhr KM, Dalaker TO, Dalen I, Bergsland N, Farbu E. Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study. Mult Scler J Exp Transl Clin 2020;6:2055217320902481. [PMID: 32064116 DOI: 10.1177/2055217320902481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Bakirtzis C, Konstantinopoulou E, Langdon DW, Grigoriadou E, Minti F, Nikolaidis I, Boziki MK, Tatsi T, Ioannidis P, Karapanayiotides T, Afrantou T, Hadjigeorgiou G, Grigoriadis N. Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study. J Neurol Sci 2018;395:106-12. [PMID: 30308444 DOI: 10.1016/j.jns.2018.10.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
162 DePauw EM, Rouhani M, Flanagan AM, Ng AV. Forearm muscle mitochondrial capacity and resting oxygen uptake: Relationship to symptomatic fatigue in persons with multiple sclerosis. Mult Scler J Exp Transl Clin 2021;7:20552173211028875. [PMID: 34262786 DOI: 10.1177/20552173211028875] [Reference Citation Analysis]
163 Ontaneda D, Cohen JA, Amato MP. Clinical outcome measures for progressive MS trials. Mult Scler 2017;23:1627-35. [PMID: 29041863 DOI: 10.1177/1352458517729465] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
164 Sun Y, Feng H, Zou T, Hou M, Jin Y, Gu C, Wang Y, Li J, Liu M, Zhang M, Gao Y. Assessment of risk factors for postoperative cognitive dysfunction after coronary artery bypass surgery: a single-center retrospective cohort study. Biosci Rep 2021;41:BSR20190719. [PMID: 33511391 DOI: 10.1042/BSR20190719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Zhang J, Cortese R, De Stefano N, Giorgio A. Structural and Functional Connectivity Substrates of Cognitive Impairment in Multiple Sclerosis. Front Neurol 2021;12:671894. [PMID: 34305785 DOI: 10.3389/fneur.2021.671894] [Reference Citation Analysis]
166 Has Silemek AC, Ranjeva JP, Audoin B, Heesen C, Gold SM, Kühn S, Weygandt M, Stellmann JP. Delayed access to conscious processing in multiple sclerosis: Reduced cortical activation and impaired structural connectivity. Hum Brain Mapp 2021;42:3379-95. [PMID: 33826184 DOI: 10.1002/hbm.25440] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
167 Koch MW, Mostert J, Repovic P, Bowen JD, Uitdehaag B, Cutter G. Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis. Neurology 2021;96:e111-20. [PMID: 33106389 DOI: 10.1212/WNL.0000000000011123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
168 Santangelo G, Altieri M, Gallo A, Trojano L. Does cognitive reserve play any role in multiple sclerosis? A meta-analytic study. Multiple Sclerosis and Related Disorders 2019;30:265-76. [DOI: 10.1016/j.msard.2019.02.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
169 McKay KA, Manouchehrinia A, Berrigan L, Fisk JD, Olsson T, Hillert J. Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis. JAMA Neurol 2019;76:1028-34. [PMID: 31206130 DOI: 10.1001/jamaneurol.2019.1546] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 14.5] [Reference Citation Analysis]
170 Renner A, Baetge SJ, Filser M, Penner I. Working ability in individuals with different disease courses of multiple sclerosis: Factors beyond physical impairment. Multiple Sclerosis and Related Disorders 2020;46:102559. [DOI: 10.1016/j.msard.2020.102559] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
171 Ryan J, Woods RL, Britt CJ, Murray AM, Shah RC, Reid CM, Wolfe R, Nelson MR, Orchard SG, Lockery JE, Trevaks RE, Storey E; behalf of the ASPREE Investigator Group on. Normative Data for the Symbol Digit Modalities Test in Older White Australians and Americans, African-Americans, and Hispanic/Latinos. J Alzheimers Dis Rep 2020;4:313-23. [PMID: 33024939 DOI: 10.3233/ADR-200194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
172 Fuchs TA, Ziccardi S, Dwyer MG, Charvet LE, Bartnik A, Campbell R, Escobar J, Hojnacki D, Kolb C, Oship D, Pol J, Shaw MT, Wojcik C, Yasin F, Weinstock-guttman B, Zivadinov R, Benedict RH. Response heterogeneity to home-based restorative cognitive rehabilitation in multiple sclerosis: An exploratory study. Multiple Sclerosis and Related Disorders 2019;34:103-11. [DOI: 10.1016/j.msard.2019.06.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
173 Lloyd A, Schofield H, Adlard N. Cognitive decline may not be adequately captured in economic evaluations of multiple sclerosis: are new treatments being undervalued? Current Medical Research and Opinion 2020;36:609-11. [DOI: 10.1080/03007995.2020.1719393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Kantorová E, Hnilicová P, Bogner W, Grendár M, Grossmann J, Kováčová S, Hečková E, Strasser B, Čierny D, Zeleňák K, Kurča E. Neurocognitive performance in relapsing-remitting multiple sclerosis patients is associated with metabolic abnormalities of the thalamus but not the hippocampus- GABA-edited 1H MRS study. Neurol Res 2021;:1-8. [PMID: 34313578 DOI: 10.1080/01616412.2021.1956282] [Reference Citation Analysis]
175 Baird JF, Cederberg KLJ, Sikes EM, Jeng B, Sasaki JE, Sandroff BM, Motl RW. Changes in Cognitive Performance With Age in Adults With Multiple Sclerosis. Cogn Behav Neurol 2019;32:201-7. [PMID: 31517704 DOI: 10.1097/WNN.0000000000000200] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 11.0] [Reference Citation Analysis]
176 Strober L, DeLuca J, Benedict RH, Jacobs A, Cohen JA, Chiaravalloti N, Hudson LD, Rudick RA, LaRocca NG; Multiple Sclerosis Outcome Assessments Consortium (MSOAC). Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis. Mult Scler 2019;25:1781-90. [PMID: 30334474 DOI: 10.1177/1352458518808204] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 17.3] [Reference Citation Analysis]
177 Jandric D, Doshi A, Scott R, Paling D, Rog D, Chataway J, Schoonheim M, Parker G, Muhlert N. A systematic review of resting state functional MRI connectivity changes and cognitive impairment in multiple sclerosis. Brain Connect 2021. [PMID: 34382408 DOI: 10.1089/brain.2021.0104] [Reference Citation Analysis]
178 Bagnato F, Gauthier SA, Laule C, Moore GRW, Bove R, Cai Z, Cohen-Adad J, Harrison DM, Klawiter EC, Morrow SA, Öz G, Rooney WD, Smith SA, Calabresi PA, Henry RG, Oh J, Ontaneda D, Pelletier D, Reich DS, Shinohara RT, Sicotte NL; NAIMS Cooperative. Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy. J Neuroimaging 2020;30:251-66. [PMID: 32418324 DOI: 10.1111/jon.12700] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
179 Van Geel F, Geurts E, Abasıyanık Z, Coninx K, Feys P. Feasibility study of a 10-week community-based program using the WalkWithMe application on physical activity, walking, fatigue and cognition in persons with Multiple Sclerosis. Mult Scler Relat Disord 2020;42:102067. [PMID: 32371377 DOI: 10.1016/j.msard.2020.102067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
180 Sumowski JF, Benedict R, Enzinger C, Filippi M, Geurts JJ, Hamalainen P, Hulst H, Inglese M, Leavitt VM, Rocca MA, Rosti-Otajarvi EM, Rao S. Cognition in multiple sclerosis: State of the field and priorities for the future. Neurology 2018;90:278-88. [PMID: 29343470 DOI: 10.1212/WNL.0000000000004977] [Cited by in Crossref: 199] [Cited by in F6Publishing: 71] [Article Influence: 66.3] [Reference Citation Analysis]
181 Wecht JM, Weir JP, Katzelnick CG, Wylie G, Eraifej M, Nguyen N, Dyson-hudson T, Bauman WA, Chiaravalloti N. Systemic and Cerebral Hemodynamic Contribution to Cognitive Performance in Spinal Cord Injury. Journal of Neurotrauma 2018;35:2957-64. [DOI: 10.1089/neu.2018.5760] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
182 Motl RW, Sandroff BM. Exercise as a Countermeasure to Declining Central Nervous System Function in Multiple Sclerosis. Clin Ther 2018;40:16-25. [PMID: 29287750 DOI: 10.1016/j.clinthera.2017.12.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
183 Bsteh G, Hegen H, Teuchner B, Amprosi M, Berek K, Ladstätter F, Wurth S, Auer M, Di Pauli F, Deisenhammer F, Berger T. Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis. Mult Scler 2019;25:196-203. [DOI: 10.1177/1352458517740216] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
184 Lin SJ, Kolind S, Liu A, McMullen K, Vavasour I, Wang ZJ, Traboulsee A, McKeown MJ. Both Stationary and Dynamic Functional Interhemispheric Connectivity Are Strongly Associated With Performance on Cognitive Tests in Multiple Sclerosis. Front Neurol 2020;11:407. [PMID: 32581993 DOI: 10.3389/fneur.2020.00407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
185 Hsu WY, Cheng CH, Zanto TP, Gazzaley A, Bove RM. Effects of Transcranial Direct Current Stimulation on Cognition, Mood, Pain, and Fatigue in Multiple Sclerosis: A Systematic Review and Meta-Analysis. Front Neurol 2021;12:626113. [PMID: 33763014 DOI: 10.3389/fneur.2021.626113] [Reference Citation Analysis]
186 Iancheva D, Trenova A, Mantarova S, Terziyski K. Functional Magnetic Resonance Imaging Correlations Between Fatigue and Cognitive Performance in Patients With Relapsing Remitting Multiple Sclerosis. Front Psychiatry 2019;10:754. [PMID: 31749716 DOI: 10.3389/fpsyt.2019.00754] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
187 Pham L, Harris T, Varosanec M, Morgan V, Kosa P, Bielekova B. Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosis. NPJ Digit Med 2021;4:36. [PMID: 33627777 DOI: 10.1038/s41746-021-00401-y] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
188 Morrow SA, Conway D, Fuchs T, Wojcik C, Unverdi M, Yasin F, Pol J, Eckert S, Hojnacki DH, Dwyer M, Zivadinov R, Weinstock-Guttman B, Benedict RH. Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses. Mult Scler 2021;27:1077-87. [PMID: 33259273 DOI: 10.1177/1352458520973618] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
189 Feasel CD, Sandroff BM, Motl RW. Aerobic reserve capacity in multiple sclerosis-Preliminary evidence. Acta Neurol Scand 2021;144:260-5. [PMID: 33914899 DOI: 10.1111/ane.13441] [Reference Citation Analysis]
190 Jakimovski D, Benedict RH, Marr K, Gandhi S, Bergsland N, Weinstock-Guttman B, Zivadinov R. Lower total cerebral arterial flow contributes to cognitive performance in multiple sclerosis patients. Mult Scler 2020;26:201-9. [PMID: 30625030 DOI: 10.1177/1352458518819608] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
191 Jakimovski D, Weinstock-guttman B, Hagemeier J, Vaughn CB, Kavak KS, Gandhi S, Bennett SE, Fuchs TA, Bergsland N, Dwyer MG, Benedict RH, Zivadinov R. Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage. Journal of the Neurological Sciences 2018;393:128-34. [DOI: 10.1016/j.jns.2018.08.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
192 Ontaneda D. Progressive Multiple Sclerosis: . CONTINUUM: Lifelong Learning in Neurology 2019;25:736-52. [DOI: 10.1212/con.0000000000000727] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
193 Hoffmann O, Gold R. [Disease-modifying treatment of secondary progressive multiple sclerosis]. Nervenarzt 2021. [PMID: 33656569 DOI: 10.1007/s00115-021-01080-6] [Reference Citation Analysis]
194 da Silva PHR, Rondinoni C, Leoni RF. Non-classical behavior of the default mode network regions during an information processing task. Brain Struct Funct 2020;225:2553-62. [PMID: 32939584 DOI: 10.1007/s00429-020-02143-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
195 Baumeister AA. Is Attention-Deficit/Hyperactivity Disorder a Risk Syndrome for Parkinson's Disease? Harv Rev Psychiatry 2021;29:142-58. [PMID: 33560690 DOI: 10.1097/HRP.0000000000000283] [Reference Citation Analysis]
196 Giedraitiene N, Kaubrys G, Kizlaitiene R. Cognition During and After Multiple Sclerosis Relapse as Assessed With the Brief International Cognitive Assessment for Multiple Sclerosis. Sci Rep 2018;8:8169. [PMID: 29802384 DOI: 10.1038/s41598-018-26449-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
197 Lam KH, van Oirschot P, den Teuling B, Hulst HE, de Jong BA, Uitdehaag B, de Groot V, Killestein J. Reliability, construct and concurrent validity of a smartphone-based cognition test in multiple sclerosis. Mult Scler 2021;:13524585211018103. [PMID: 34037472 DOI: 10.1177/13524585211018103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Simone M, Viterbo RG, Margari L, Iaffaldano P. A Randomized Computer-Assisted Rehabilitation Trial of Attention in Pediatric Multiple Sclerosis: A Post Hoc Analysis. Brain Sci 2021;11:637. [PMID: 34069276 DOI: 10.3390/brainsci11050637] [Reference Citation Analysis]
199 Silva P, Spedo C, Baldassarini C, Benini C, Ferreira D, Barreira A, Leoni R. Brain functional and effective connectivity underlying the information processing speed assessed by the Symbol Digit Modalities Test. NeuroImage 2019;184:761-70. [DOI: 10.1016/j.neuroimage.2018.09.080] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
200 de David AC, Sasaki JE, Ramari C, Tauil CB, Moraes AG, Martins F, von Glehn F, Motl RW. Validation of the Brazilian version of the patient-determined disease steps scale in persons with multiple sclerosis. Multiple Sclerosis and Related Disorders 2019;30:208-14. [DOI: 10.1016/j.msard.2019.02.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
201 Tavazzi E, Bergsland N, Kuhle J, Jakimovski D, Ramanathan M, Maceski AM, Tomic D, Hagemeier J, Kropshofer H, Leppert D, Dwyer MG, Weinstock-Guttman B, Benedict RHB, Zivadinov R. A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis. J Neurol 2020;267:802-11. [PMID: 31768628 DOI: 10.1007/s00415-019-09643-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
202 Conway DS, Planchon SM, Oh SH, Nakamura K, Thompson NR, Sakaie K, Ontaneda D. Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients. Mult Scler Relat Disord 2021;47:102635. [PMID: 33260053 DOI: 10.1016/j.msard.2020.102635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Fuchs TA, Dwyer MG, Kuceyeski A, Choudhery S, Carolus K, Li X, Mallory M, Weinstock-Guttman B, Jakimovski D, Ramasamy D, Zivadinov R, Benedict RHB. White matter tract network disruption explains reduced conscientiousness in multiple sclerosis. Hum Brain Mapp 2018;39:3682-90. [PMID: 29740964 DOI: 10.1002/hbm.24203] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
204 Gregori G, Celli A, Barnouin Y, Paudyal A, Armamento-Villareal R, Napoli N, Qualls C, Villareal DT. Cognitive response to testosterone replacement added to intensive lifestyle intervention in older men with obesity and hypogonadism: prespecified secondary analyses of a randomized clinical trial. Am J Clin Nutr 2021:nqab253. [PMID: 34375393 DOI: 10.1093/ajcn/nqab253] [Reference Citation Analysis]
205 Bisio A, Pedullà L, Bonzano L, Tacchino A, Brichetto G, Bove M. The kinematics of handwriting movements as expression of cognitive and sensorimotor impairments in people with multiple sclerosis. Sci Rep 2017;7:17730. [PMID: 29255220 DOI: 10.1038/s41598-017-18066-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
206 Solanky BS, John NA, DeAngelis F, Stutters J, Prados F, Schneider T, Parker RA, Weir CJ, Monteverdi A, Plantone D, Doshi A, MacManus D, Marshall I, Barkhof F, Gandini Wheeler-Kingshott CAM, Chataway J; MS-SMART Investigators. NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study. AJNR Am J Neuroradiol 2020;41:2209-18. [PMID: 33154071 DOI: 10.3174/ajnr.A6809] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
207 Gromisch ES, Portnoy JG, Foley FW. Comparison of the abbreviated minimal assessment of cognitive function in multiple sclerosis (aMACFIMS) and the brief international cognitive assessment for multiple sclerosis (BICAMS). J Neurol Sci 2018;388:70-5. [PMID: 29627034 DOI: 10.1016/j.jns.2018.03.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
208 Wojcik CM, Rao SM, Schembri AJ, Drake AS, Maruff P, Schindler D, Alberts J, Yasin F, Pol J, Weinstock-guttman B, Benedict RH. Necessity of technicians for computerized neuropsychological assessment devices in multiple sclerosis. Mult Scler 2020;26:109-13. [DOI: 10.1177/1352458518813287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
209 Sandry J, Simonet DV, Brandstadter R, Krieger S, Katz Sand I, Graney RA, Buchanan AV, Lall S, Sumowski JF. The Symbol Digit Modalities Test (SDMT) is sensitive but non-specific in MS: Lexical access speed, memory, and information processing speed independently contribute to SDMT performance. Mult Scler Relat Disord 2021;51:102950. [PMID: 33887609 DOI: 10.1016/j.msard.2021.102950] [Reference Citation Analysis]
210 Wang M, Su P, Liu Y, Zhang X, Yan J, An X, Wang X, Gu S. Abnormal expression of circRNA_089763 in the plasma exosomes of patients with post‑operative cognitive dysfunction after coronary artery bypass grafting. Mol Med Rep 2019;20:2549-62. [PMID: 31524256 DOI: 10.3892/mmr.2019.10521] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
211 Arm J, Oeltzschner G, Al-Iedani O, Lea R, Lechner-Scott J, Ramadan S. Altered in vivo brain GABA and glutamate levels are associated with multiple sclerosis central fatigue. Eur J Radiol 2021;137:109610. [PMID: 33657474 DOI: 10.1016/j.ejrad.2021.109610] [Reference Citation Analysis]
212 Abdel Naseer M, Fathi S, Roshdy NK, Labib DM, Khalil DH, Ibrahim W, Magdy R. Cognitive and physical disability in Egyptian patients with multiple sclerosis: genetic and optical coherence tomography study. Neurol Res 2019;41:644-51. [PMID: 31025605 DOI: 10.1080/01616412.2019.1609203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
213 Renner A, Baetge SJ, Filser M, Ullrich S, Lassek C, Penner I. Characterizing cognitive deficits and potential predictors in multiple sclerosis: A large nationwide study applying Brief International Cognitive Assessment for Multiple Sclerosis in standard clinical care. J Neuropsychol 2020;14:347-69. [DOI: 10.1111/jnp.12202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
214 Ziemssen T, Hoffmann O, Klotz L, Schreiber H, Weber MS, Rauser B. Gaining First Insights on Secondary Progressive Multiple Sclerosis Patients Treated With Siponimod in Clinical Routine: Protocol of the Noninterventional Study AMASIA. JMIR Res Protoc 2020;9:e19598. [PMID: 32499214 DOI: 10.2196/19598] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
215 De Angelis F, Plantone D, Chataway J. Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview. CNS Drugs 2018;32:499-526. [PMID: 29968175 DOI: 10.1007/s40263-018-0538-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
216 Jacobsen C, Zivadinov R, Myhr KM, Dalaker TO, Dalen I, Benedict RH, Bergsland N, Farbu E. Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study. Mult Scler J Exp Transl Clin 2021;7:2055217321992394. [PMID: 33623706 DOI: 10.1177/2055217321992394] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
217 Androwis GJ, Sandroff BM, Niewrzol P, Fakhoury F, Wylie GR, Yue G, DeLuca J. A pilot randomized controlled trial of robotic exoskeleton-assisted exercise rehabilitation in multiple sclerosis. Mult Scler Relat Disord 2021;51:102936. [PMID: 33878619 DOI: 10.1016/j.msard.2021.102936] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
218 Perrotta ML, Saha P, Zawadzki R, Beidelman M, Ingelsson E, Lui GK, Priest JR. Adults With Mild-to-Moderate Congenital Heart Disease Demonstrate Measurable Neurocognitive Deficits. J Am Heart Assoc 2020;9:e015379. [PMID: 32981450 DOI: 10.1161/JAHA.119.015379] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
219 Savini G, Pardini M, Castellazzi G, Lascialfari A, Chard D, D'Angelo E, Gandini Wheeler-Kingshott CAM. Default Mode Network Structural Integrity and Cerebellar Connectivity Predict Information Processing Speed Deficit in Multiple Sclerosis. Front Cell Neurosci 2019;13:21. [PMID: 30853896 DOI: 10.3389/fncel.2019.00021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
220 Griffa A, Bommarito G, Assal F, Herrmann FR, Van De Ville D, Allali G. Dynamic functional networks in idiopathic normal pressure hydrocephalus: Alterations and reversibility by CSF tap test. Hum Brain Mapp 2021;42:1485-502. [PMID: 33296129 DOI: 10.1002/hbm.25308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Saposnik G, Sotoca J, Sempere ÁP, Candeliere-merlicco A, Díaz-abós P, Tobler PN, Terzaghi M, Maurino J. Therapeutic status quo in patients with relapsing-remitting multiple sclerosis: A sign of poor self-perception of their clinical status? Multiple Sclerosis and Related Disorders 2020;45:102354. [DOI: 10.1016/j.msard.2020.102354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
222 Benedict RHB, Amato MP, DeLuca J, Geurts JJG. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol 2020;19:860-71. [PMID: 32949546 DOI: 10.1016/S1474-4422(20)30277-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 37.0] [Reference Citation Analysis]
223 Sokolov AA, Grivaz P, Bove R. Cognitive Deficits in Multiple Sclerosis: Recent Advances in Treatment and Neurorehabilitation. Curr Treat Options Neurol 2018;20:53. [PMID: 30345468 DOI: 10.1007/s11940-018-0538-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
224 Abasıyanık Z, Kahraman T, Ertekin Ö, Baba C, Özakbaş S. Prevalence and determinants of falls in persons with multiple sclerosis without a clinical disability. Mult Scler Relat Disord 2021;49:102771. [PMID: 33493789 DOI: 10.1016/j.msard.2021.102771] [Reference Citation Analysis]
225 Abasıyanık Z, Ertekin Ö, Kahraman T, Yigit P, Özakbaş S. The effects of Clinical Pilates training on walking, balance, fall risk, respiratory, and cognitive functions in persons with multiple sclerosis: A randomized controlled trial. EXPLORE 2020;16:12-20. [DOI: 10.1016/j.explore.2019.07.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
226 Shema-Shiratzky S, Hillel I, Mirelman A, Regev K, Hsieh KL, Karni A, Devos H, Sosnoff JJ, Hausdorff JM. A wearable sensor identifies alterations in community ambulation in multiple sclerosis: contributors to real-world gait quality and physical activity. J Neurol 2020;267:1912-21. [PMID: 32166481 DOI: 10.1007/s00415-020-09759-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
227 Elwick H, Topcu G, Allen CM, Drummond A, Evangelou N, Nair RD. Cognitive measures used in adults with multiple sclerosis: A systematic review. Neuropsychol Rehabil 2021;:1-18. [PMID: 34121613 DOI: 10.1080/09602011.2021.1936080] [Reference Citation Analysis]